In this study, we hypothesized that combining G6PD inhibition with 5-ALA-mediated PDT would overwhelm GSH defenses and amplify the activity of ROS, resulting in the induction of enhanced cytotoxicity against MYCN-amplified neuroblastoma cells. The gene discussed is MYCN; the disease is neuroblastoma.